The market expert advised investors to avoid the sector for the time being and wait for the situation between India and the US to stabilise, recommending staying away from pharma stocks across large-cap, mid-cap and small-cap segments.
The market expert advised investors to avoid the sector for the time being and wait for the situation between India and the US to stabilise, recommending staying away from pharma stocks across large-cap, mid-cap and small-cap segments.